The future of computing is being rewritten by biology. In this landmark session, Axios Managing Editor for Science & World, Alison Snyder, sits down with Stanford professor and synthetic biology pioneer Drew Endy and Microsoft CTO Kevin Scott to explore how programming living systems will transform the architecture of innovation. From designing cells with logic and memory to harnessing biological systems for sensing, computation, and decision-making, biology is becoming a powerful substrate for information processing. Join us for a forward-looking conversation on the convergence of synthetic biology and computing—and what it means for the future of technology, medicine, and planetary health.

This invite-only luncheon is a unique opportunity to connect with fellow biotech and deep tech CEO's facing today’s most pressing financial challenges. Hosted at SynBioBeta 2025, the gathering will foster candid peer discussion and high-level networking in an intimate setting. The session, Navigating Today’s Economic Challenges: Leading Through Uncertainty, will feature a conversation moderated by Alison Snyder from Axios, bringing together Hermann Hauser (Amadeus Capital) and David Choi (JPMorgan), who will share their perspectives on the current economic landscape, shifting investor expectations, and the strategies companies are adopting to stay resilient and competitive. Against a backdrop of market volatility, capital constraints, and global uncertainty, this conversation offers grounded insights and practical guidance for executives leading through turbulent times. https://lu.ma/4ppwczeh

The latest collaborative drug discovery AI technologies from Nvidia and CDD